Synopsys financials
$415.09−0.60%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Oct 31 | FY24 Oct 31 | FY23 Oct 31 | FY22 Oct 31 | FY21 Oct 31 | FY20 Oct 31 | FY19 Oct 31 | FY18 Oct 31 | FY17 Oct 31 | FY16 Oct 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7.05B | $6.13B | $5.32B | $4.62B | $4.20B | $3.69B | $3.36B | $3.12B | $2.72B | $2.42B |
| Gross profit | $5.43B | $4.88B | $4.29B | $3.76B | $3.34B | $2.89B | $2.61B | $2.39B | $2.07B | $1.88B |
| Gross margin | 77.0% | 79.7% | 80.6% | 81.5% | 79.5% | 78.4% | 77.6% | 76.4% | 76.0% | 77.6% |
| Operating income | $914.9M | $1.36B | $1.27B | $1.15B | $734.8M | $620.1M | $520.2M | $360.2M | $347.6M | $317.4M |
| Net income | $1.33B | $2.26B | $1.23B | $984.6M | $757.5M | $664.3M | $532.4M | $432.5M | $136.6M | $266.8M |
| Net margin | 18.9% | 36.9% | 23.1% | 21.3% | 18.0% | 18.0% | 15.8% | 13.9% | 5.0% | 11.0% |
| Diluted EPS | $8.04 | $14.51 | $7.92 | $6.29 | $4.81 | $4.27 | $3.45 | $2.82 | $0.88 | $1.73 |
| EBITDA | $1.58B | $1.65B | $1.57B | $1.46B | $1.04B | $927.4M | $831.8M | $582.4M | $573.6M | $534.1M |
| Operating cash flow | $1.52B | $1.41B | $1.70B | $1.74B | $1.49B | $991.3M | $800.5M | $424.4M | $632.5M | $586.6M |
| Free cash flow | $1.35B | $1.27B | $1.51B | $1.60B | $1.40B | $832.6M | $598.1M | $322.5M | $558.9M | $515.6M |
| Diluted shares | 165.7M | 155.9M | 155.2M | 156.5M | 157.3M | 155.7M | 154.2M | 153.4M | 154.9M | 154.7M |
Balance sheet
| Period end | Oct 31 | Oct 31 | Oct 31 | Oct 31 | Oct 31 | Oct 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $2.89B | $3.90B | $1.43B | $1.42B | $1.43B | $1.24B |
| Short-term investments | $72.9M | $153.9M | $151.6M | $147.9M | $147.9M | $0.00 |
| Total debt | $13.48B | $15.6M | $18.1M | $20.8M | $100.1M | $127.9M |
| Total assets | $48.22B | $13.07B | $10.33B | $9.42B | $8.75B | $8.03B |
| Total liabilities | $19.90B | $4.05B | $4.15B | $3.86B | $3.45B | $3.12B |
| Shareholders' equity | $28.33B | $8.99B | $6.15B | $5.52B | $5.30B | $4.91B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology